Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
- Rather than focus on one guideline or another, physicians should focus on a model of informed decision making
- A dichotomy exists between those that treat prostate cancer and those that do not
- PSA testing adds value but also brings a potential for harm
- Following PSA testing, a physician should be open to the concept of surveillance before making a decision